|
Recent News & Comments About administration drug food
FDA: Food makers to acknowledge bug-based additives (Newsday)
After a decade of pressure from a consumer advocacy group, the U.S. Food and Drug Administration will require the food industry to disclose a little known fact: The food dye that goes by the name of carmine - and several other aliases - is made from the crushed bodies of the cochineal insect.
Prism Pharmaceuticals arrythmia drug OK’d (Philadelphia Business Journal)
The Food and Drug Administration on Monday approved a new drug application filed by Prism Pharmaceuticals for its cardiac arrhythmia drug Nexterone. (WYE)
Stevia-based sweeteners may soon get FDA approval (Seattle Times)
The Food and Drug Administration soon may give the green light to zero-calorie sweeteners derived from stevia.
FDA Prevents Two Dairies From Adulterating Animal Drugs And Food (Medical News Today)
The U.S. Food and Drug Administration announced today that the District Court for the District of New Mexico has enjoined Do-Rene and Clover Knolls Dairies and their owners, Douglas B. Handley and Irene Handley, from adulterating new animal drugs and introducing adulterated food into commerce. Both companies are based in Clovis, N.M.
Genta Summarizes Phase 2 Activity and Receives Orphan Drug Designation in Gastric Cancer for Tesetaxel, a Leading Oral ... (Centre Daily Times)
Genta Incorporated (OTCBB: GNTA) announced today that the Company has received notice from the U.S. Food and Drug Administration (FDA) that tesetaxel, the latest addition to Genta’s oncology product portfolio, has been granted designation as an “Orphan Drug” for treatment of patients with advanced gastric cancer. Orphan drug status provides for a period of marketing exclusivity, certain tax ...
Pharmaceutical Companies Seek Clarity On Evidence Needed For Drug Label Change (Medical News Today)
With the discovery of a growing number of predictive biomarkers for existing drugs, the question of when and how to add pharmacogenetic information to drug labels has taken on greater urgency. On December 16 the Oncologic Drug Advisory Committee (ODAC) of the Food and Drug Administration (FDA) met in Gaithersburg, MD with representatives from pharmaceutical companies Amgen and Imclone.
QuantRx gets FDA test clearance (The Philadelphia Inquirer)
QuantRx Biomedical Corp., a Doylestown diagnostic company, said today that U.S. Food and Drug Administration had granted clearance on its RapidSense methamphetamine drug test. The company said it is waiting for FDA approval of related testing products and plans to put the group on the market in the third quarter of this year.
Medtronic gets defibrillator lawsuit dismissed (AP via Yahoo! Finance)
Medtronic Inc. said Tuesday a U.S. District Court dismissed with prejudice lawsuits over lead wires to an implantable defibrillator on the grounds that Food and Drug Administration approval protects the makers from lawsuits.
Genta Summarizes Phase 2 Activity and Receives Orphan Drug Designation in Gastric Cancer for Tesetaxel, a Leading Oral ... (Business Wire via Yahoo! Finance)
BERKELEY HEIGHTS, N.J.----Genta Incorporated announced today that the Company has received notice from the U.S. Food and Drug Administration that tesetaxel, the latest addition to Genta’s oncology product portfolio, has been granted designation as an “Orphan Drug” for treatment of patients with advanced gastric cancer.
Kennedy Wants Cigarette Risks Regulated in Obama-Backed Bill (Bloomberg)
Jan. 6 (Bloomberg) -- The U.S. Food and Drug Administration would have the power to regulate tobacco under legislation that Senator Edward Kennedy will introduce.
 |
|
Free Diet Articles
|
